Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain

Colaboración

Año: 2025

Alvarez-Gallego, R; Pazo-Cid, R; de San Vicente, BL; Macarulla, T; Martinez, E; Garicano, F; Hernández, I; Granja, M; Ghanem, I; Martinez, J; Ribera, P; Diaz, R; Valadés, JIM; Angeles, MC; Cubillo, A

Título: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

• Q2